Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06934057 |
| Title | Cabozantinib and Nivolumab Among Older Patients With Renal Cell Carcinoma (CABOLD) |
| Acronym | CABOLD |
| Recruitment | Not yet recruiting |
| Gender | both |
| Phase | FDA approved |
| Variant Requirements | No |
| Sponsors | Gustave Roussy, Cancer Campus, Grand Paris |
| Indications | |
| Therapies | |
| Age Groups: | senior |
| Covered Countries | FRA |